139 related articles for article (PubMed ID: 8754541)
1. [The use of tactivin in the combined treatment and prevention of complications in reconstructive operations on the bones of the facial skeleton].
Volozhin AI; Sazhina TG; Chergeshtov IuI; Arion VIa; Panin MG; Shipkova TP
Stomatologiia (Mosk); 1996; 75(2):46-8. PubMed ID: 8754541
[TBL] [Abstract][Full Text] [Related]
2. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
[TBL] [Abstract][Full Text] [Related]
3. [The use of tactivin for treating patients with IHD].
Klimov AN; Almazov VA; Nagornev VA; Denisenko AD; Pigarevskiĭ PV; Ogurtsov RP; Sergeeva EG; Sitnikova OD; Popov VG
Ter Arkh; 1995; 67(9):24-7. PubMed ID: 7495034
[TBL] [Abstract][Full Text] [Related]
4. [Tactivin in combined treatment of patients with pulmonary tuberculosis associated with gastrointestinal diseases].
Zhukova EM
Probl Tuberk; 1995; (3):25-7. PubMed ID: 7617628
[TBL] [Abstract][Full Text] [Related]
5. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
Petunina NA; Balabolkin MI; Arion VIa
Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
[TBL] [Abstract][Full Text] [Related]
6. [T-activin in the treatment of patients with recurrent aphthous stomatitis].
Terekhova NV; Khazanova VV; Zemskaia EA; Bykova IA; Filonenko OF; Kosorukova NIa; Rabinovich IM
Stomatologiia (Mosk); 1991; (2):35-7. PubMed ID: 1853375
[TBL] [Abstract][Full Text] [Related]
7. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
Karimov ShI; Kim VF; Iunusov IR
Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432
[TBL] [Abstract][Full Text] [Related]
8. [An ultrastructural and morphometric analysis of the polymorphonuclear leukocytes from lesion foci and from the peripheral blood in patients with a gonorrhea-chlamydial urogenital infection before and during treatment with doxycycline combined with T-activin].
Delektorskiĭ VV; Danielian EE; Iashkova GN; Kubanova AA; Khachikian KhM
Vestn Dermatol Venerol; 1990; (2):15-21. PubMed ID: 2343663
[TBL] [Abstract][Full Text] [Related]
9. [Prevention and treatment of postoperative complications of hepatic echinococcosis].
Akhmedov RM; Ochilov UB; Mirkhodzhaev IA; Komilov TS; Makliev BIu
Med Parazitol (Mosk); 2003; (2):18-21. PubMed ID: 12886586
[TBL] [Abstract][Full Text] [Related]
10. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
Shafer NP
Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
[TBL] [Abstract][Full Text] [Related]
11. [Clinico-immunologic effect of tactivin in chronic myeloid leukemia].
Abdulkadyrov KM; Guseva SA
Gematol Transfuziol; 1994; 39(5):19-22. PubMed ID: 7896024
[TBL] [Abstract][Full Text] [Related]
12. [Use of tactivin and imunofan for the treatment of patients with endometrial carcinoma].
Venediktova MG
Eksp Klin Farmakol; 2001; 64(5):46-9. PubMed ID: 11764501
[TBL] [Abstract][Full Text] [Related]
13. [Combined detoxification and immunocorrective therapy in patients with peritonitis].
Shkrob LO; Fedotov PA; Ermakova NG
Khirurgiia (Mosk); 1994 Mar; (3):20-2. PubMed ID: 8007606
[TBL] [Abstract][Full Text] [Related]
14. [The use of taktivin for modulating the functional activity of the neutrophilic granulocytes in patients with systemic lupus erythematosus].
Romanov VA; Borodin AG; Krylov VL
Ter Arkh; 1992; 64(5):65-9. PubMed ID: 1455381
[TBL] [Abstract][Full Text] [Related]
15. [Interferon and tactivin in the treatment program for non-Hodgkin's lymphomas in children during remission].
Makhonova LA; Kiselev AV; Gordina GA; Kadagidze ZG
Vopr Onkol; 1995; 41(2):80-1. PubMed ID: 7483451
[No Abstract] [Full Text] [Related]
16. [A clinico-immunological assessment of the efficacy of combined methods of treating patients with different immunopathological forms of focal scleroderma].
Suchkova TN; Sharova NM; Suchkov SV
Vestn Dermatol Venerol; 1990; (2):47-50. PubMed ID: 2343669
[TBL] [Abstract][Full Text] [Related]
17. [A case of tactivin side effects in patient with eczema].
Zaerko VV
Klin Med (Mosk); 1991 May; 69(5):97-8. PubMed ID: 1857089
[No Abstract] [Full Text] [Related]
18. [The use of taktivin in experimental apical periodontitis exacerbated by a secondary immunodeficiency state].
Zyrianov GV; Dmitrieva LA; Frolova TM; Belopol'skiĭ AA; Babaian SS
Stomatologiia (Mosk); 1993; 72(2):10-3. PubMed ID: 8048117
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
[No Abstract] [Full Text] [Related]
20. [Immunocorrective therapy of pyelonephritis in children].
Kirillov VI; Zernov NG; Arion VIa; Tebloeva LT; Riabchikov OP
Urol Nefrol (Mosk); 1989; (5):17-21. PubMed ID: 2595860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
